Diabetes Drug Poses Heart Attack Risk

Representing Orlando, Tampa, Miami and Nearby Areas of Florida

According to a new study, the widely prescribed Avandia, a drug used to treat Type 2 diabetes, poses a greater risk of heart attack and death than previously thought. GlaxoSmithKline put Avandia on the market about 8 years ago. Since then, about 6 million people worldwide have taken the medication used to treat the most common form of diabetes which is linked to obesity. Results of dozens of studies now reveal a 45% greater risk of heart attack according to an analysis published online by the New England Journal of Medicine. Type 2 diabetes occurs when the body does not make enough insulin or cannot effectively utilize the insulin it does produce. Avandia is supposed to help sensitize the body to insulin and had been considered a breakthrough medicine for controlling blood sugar. Several experts have said that this is another “Vioxx-like” example of the Food and Drug Administration failing to detect a safety problem before millions of people had bought and taken the drug.